Home › Respiratory Distress Syndrome › California › Fresno
Respiratory Distress Syndrome clinical trials in Fresno, CA
6 studies for Respiratory Distress Syndrome are looking for participants at sites in and around Fresno (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Fresno
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RecruitingPhase 2
- Community Regional Medical Center, Fresno
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RecruitingPhase 2
- Community Regional Medical Center, Fresno
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RecruitingPhase 2
- Community Regional Medical Center, Fresno
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RecruitingPhase 2
- Community Regional Medical Center, Fresno
The APS Phenotyping Study
RecruitingObservational study
- Fresno Community Hospital and Medical Center, Fresno
Respiratory Distress Syndrome trials in other cities
- Houston, TX11 studies
- New York City, NY10 studies
- West Jordan, UT9 studies
- Boston, MA8 studies
- Durham, NC8 studies
- Denver, CO8 studies
- Birmingham, AL7 studies
- Ann Arbor, MI7 studies
- Charlottesville, VA7 studies
- The Bronx, NY7 studies
- Cleveland, OH7 studies
- Oklahoma City, OK7 studies
Other studies in Fresno
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Breast Cancer6 studies
- Acute Myeloid Leukemia5 studies
- Migraine5 studies
- Steatotic Liver Disease5 studies
- Prostate Cancer5 studies
- Ovarian Cancer4 studies
- Acute Lung Injury4 studies
- Cancer (all types)4 studies
- Burkitt Lymphoma4 studies
- Myelodysplastic Syndromes3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.